This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Clinical
Salt substitutes reduce risk of strokes and cardiovascular events
Read more
Higher risk of hospitalisation from delta COVID-19 variant
Read more
Intensive blood pressure control in the elderly reduces cardiovascular outcomes
Read more
Injectable cholesterol lowering drug approved by NICE
Read more
Non-traditional cardiovascular risk factors higher in women
Read more
Probiotics reduce risk of developing atopic eczema
Read more
Biologics most effective in treatment-resistant chronic spontaneous urticaria
Read more
Risk of clotting disorders higher after COVID-19 than vaccination
Read more
Half of paediatric opioid prescriptions deemed high risk
Read more
Use of anti-hypertensives associated with reduced risk of colorectal cancer mortality
Read more
Major barriers to COVID-19 mitigation strategies in African countries
Read more
EU approves bimekizumab for moderate to severe psoriasis
Read more
Transmission of COVID-19 more likely from very young children
Read more
Risk of high refractive error greatest among children with diabetic mothers
Read more
Persistent endothelial dysfunction a potential cause of long COVID
Read more
COVID-19 an independent risk factor for myocardial infarction and ischaemic stroke
Read more
No benefit from early convalescent plasma in high-risk COVID-19 patients
Read more
Page 70 of 200
« First
«
...
10
20
30
...
68
69
70
71
72
...
80
90
100
...
»
Last »
Popular articles
Third of patients in favour of AI-supported consultations and clinical documents, study finds
18 April, 2024
Telemedicine strategy post-acute coronary syndrome drives efficiencies and safety, study finds
17 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
x
Search for: